231 related articles for article (PubMed ID: 34889372)
1. Blast and accelerated phase CML: room for improvement.
How J; Venkataraman V; Hobbs GS
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):122-128. PubMed ID: 34889372
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
Jain P; Kantarjian HM; Ghorab A; Sasaki K; Jabbour EJ; Nogueras Gonzalez G; Kanagal-Shamanna R; Issa GC; Garcia-Manero G; Kc D; Dellasala S; Pierce S; Konopleva M; Wierda WG; Verstovsek S; Daver NG; Kadia TM; Borthakur G; O'Brien S; Estrov Z; Ravandi F; Cortes JE
Cancer; 2017 Nov; 123(22):4391-4402. PubMed ID: 28743165
[TBL] [Abstract][Full Text] [Related]
3. Impact of frontline treatment approach on outcomes of myeloid blast phase CML.
Saxena K; Jabbour E; Issa G; Sasaki K; Ravandi F; Maiti A; Daver N; Kadia T; DiNardo CD; Konopleva M; Cortes JE; Yilmaz M; Chien K; Pierce S; Kantarjian H; Short NJ
J Hematol Oncol; 2021 Jun; 14(1):94. PubMed ID: 34130720
[TBL] [Abstract][Full Text] [Related]
4. An Update on the Management of Advanced Phase Chronic Myeloid Leukemia.
Short NJ; Senapati J; Jabbour E
Curr Hematol Malig Rep; 2023 Dec; 18(6):234-242. PubMed ID: 37651057
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and management of accelerated and blast phases of chronic myeloid leukemia.
Senapati J; Jabbour E; Kantarjian H; Short NJ
Leukemia; 2023 Jan; 37(1):5-17. PubMed ID: 36309558
[TBL] [Abstract][Full Text] [Related]
6. Outcomes Following Bone Marrow Transplantation in Children With Accelerated Phase or Blast Crisis Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitors.
Shulman DS; Lee MA; Lehmann LE; Margossian SP
J Pediatr Hematol Oncol; 2016 Nov; 38(8):610-614. PubMed ID: 27403776
[TBL] [Abstract][Full Text] [Related]
7. [Management of advanced-phase chronic myeloid leukemia].
Kitanaka A
Rinsho Ketsueki; 2016; 57(10):1962-1971. PubMed ID: 27725594
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing and managing advanced chronic myeloid leukemia.
Deininger MW
Am Soc Clin Oncol Educ Book; 2015; ():e381-8. PubMed ID: 25993200
[TBL] [Abstract][Full Text] [Related]
9. Favourable outcome of de novo advanced phases of childhood chronic myeloid leukaemia.
Millot F; Maledon N; Guilhot J; Güneş AM; Kalwak K; Suttorp M
Eur J Cancer; 2019 Jul; 115():17-23. PubMed ID: 31082688
[TBL] [Abstract][Full Text] [Related]
10. Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations.
Sembill S; Ampatzidou M; Chaudhury S; Dworzak M; Kalwak K; Karow A; Kiani A; Krumbholz M; Luesink M; Naumann-Bartsch N; De Moerloose B; Osborn M; Schultz KR; Sedlacek P; Giona F; Zwaan CM; Shimada H; Versluijs B; Millot F; Hijiya N; Suttorp M; Metzler M
Leukemia; 2023 Mar; 37(3):505-517. PubMed ID: 36707619
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life during bosutinib (SKI-606) therapy in patients with advanced chronic myeloid leukemia after imatinib failure.
Whiteley J; Reisman A; Shapiro M; Cortes J; Cella D
Curr Med Res Opin; 2016 Aug; 32(8):1325-34. PubMed ID: 27045164
[TBL] [Abstract][Full Text] [Related]
12. Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemia.
Jabbour EJ; Hughes TP; Cortés JE; Kantarjian HM; Hochhaus A
Leuk Lymphoma; 2014 Jul; 55(7):1451-62. PubMed ID: 24050507
[TBL] [Abstract][Full Text] [Related]
13. Accelerated Phase CML: Outcomes in Newly Diagnosed vs. Progression From Chronic Phase.
Mukherjee S; Kalaycio M
Curr Hematol Malig Rep; 2016 Apr; 11(2):86-93. PubMed ID: 26932346
[TBL] [Abstract][Full Text] [Related]
14. How has treatment changed for blast phase chronic myeloid leukemia patients in the tyrosine kinase inhibitor era? A review of efficacy and safety.
Perrone S; Massaro F; Alimena G; Breccia M
Expert Opin Pharmacother; 2016 Aug; 17(11):1517-26. PubMed ID: 27231757
[TBL] [Abstract][Full Text] [Related]
15. Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions.
Osman AEG; Deininger MW
Blood Rev; 2021 Sep; 49():100825. PubMed ID: 33773846
[TBL] [Abstract][Full Text] [Related]
16. Management of chronic myeloid leukemia in blast crisis.
Saußele S; Silver RT
Ann Hematol; 2015 Apr; 94 Suppl 2():S159-65. PubMed ID: 25814082
[TBL] [Abstract][Full Text] [Related]
17. Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients.
Hu B; Lin X; Lee HC; Huang X; Tidwell RSS; Ahn KW; Hu ZH; Jabbour E; Verstovsek S; Ravandi F; Garcia-Manero G; Kharfan-Dabaja MA; Hossain NM; Marks DI; Kamble RT; Inamoto Y; Kindwall-Keller T; Saad A; Litzow MR; Savani BN; Hale GA; Bacher U; Gerds AT; Liesveld JL; Ustun C; Olsson RF; Daly A; Grunwald MR; Solh M; DeFilipp Z; Aljurf M; Wirk B; Akpek G; Nishihori T; Cerny J; Seo S; Hsu JW; Champlin R; de Lima M; Alyea E; Popat U; Sobecks R; Scott BL; Kantarjian H; Cortes J; Saber W
Leuk Lymphoma; 2020 Dec; 61(12):2811-2820. PubMed ID: 32662346
[TBL] [Abstract][Full Text] [Related]
18. When to Consider Allogeneic Transplantation in CML.
Radich J
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S93-5. PubMed ID: 27521333
[TBL] [Abstract][Full Text] [Related]
19. A Case Report of Chronic Myelogenous Leukemia Presenting as Blastic Crisis with a T-Cell Acute Lymphoblastic Leukemia Phenotype: Awareness of a Rare Entity.
Efstathopoulou M; Zoi K; Siakantaris MP; Koumbi D; Zannou A; Triantafyllou EF; Tsourouflis G; Lakiotaki E; Vassilakopoulos TP; Angelopoulou MK
Acta Haematol; 2023; 146(6):530-537. PubMed ID: 37557081
[TBL] [Abstract][Full Text] [Related]
20. How I treat CML blast crisis.
Hehlmann R
Blood; 2012 Jul; 120(4):737-47. PubMed ID: 22653972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
